These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36746630)

  • 1. Intranasal fentanyl works-Why are we not using it more to treat acute pain in sickle cell disease?
    Oni MO; Archer NM
    Am J Hematol; 2023 Apr; 98(4):564-565. PubMed ID: 36746630
    [No Abstract]   [Full Text] [Related]  

  • 2. Outpatient pain clinic and intranasal fentanyl to improve sickle cell disease outcomes.
    Myrick R; Blakemore S; Waite E; Pernell B; Madan-Swain A; Hilliard L; Lebensburger J
    Pediatr Blood Cancer; 2020 Oct; 67(10):e28648. PubMed ID: 32798305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Still seeking balance in opioid management for acute sickle cell disease pain.
    Fasipe TA; Hulbert ML
    Pediatr Blood Cancer; 2022 Aug; 69(8):e29741. PubMed ID: 35522166
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of the acute painful crisis in sickle cell disease- a re-evaluation of the use of opioids in adult patients.
    Telfer P; Bahal N; Lo A; Challands J
    Br J Haematol; 2014 Jul; 166(2):157-64. PubMed ID: 24750050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute pain in adolescents and young adults with sickle cell disease: Delayed and increased opioid dosing following transition to adult care.
    Stehouwer N; Edge P; Katie Park B; Piccone C; Little J
    Am J Hematol; 2017 Apr; 92(4):E40-E42. PubMed ID: 28066934
    [No Abstract]   [Full Text] [Related]  

  • 6. Opioid treatment for acute and chronic pain in patients with sickle cell disease.
    Carroll CP
    Neurosci Lett; 2020 Jan; 714():134534. PubMed ID: 31593753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fentanyl for breakthrough pain: a systematic review.
    Davis MP
    Expert Rev Neurother; 2011 Aug; 11(8):1197-216. PubMed ID: 21797660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological interventions for painful sickle cell vaso-occlusive crises in adults.
    Cooper TE; Hambleton IR; Ballas SK; Johnston BA; Wiffen PJ
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31742673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid utilization patterns in United States individuals with sickle cell disease.
    Ballas SK; Kanter J; Agodoa I; Howard R; Wade S; Noxon V; Dampier C
    Am J Hematol; 2018 Oct; 93(10):E345-E347. PubMed ID: 30051929
    [No Abstract]   [Full Text] [Related]  

  • 10. Intranasal fentanyl improves time to analgesic delivery in sickle cell pain crises.
    Kelly GS; Stewart RW; Strouse JJ; Anders JF
    Am J Emerg Med; 2018 Jul; 36(7):1305-1307. PubMed ID: 29128141
    [No Abstract]   [Full Text] [Related]  

  • 11. Randomized Controlled Feasibility Trial of Intranasal Ketamine Compared to Intranasal Fentanyl for Analgesia in Children with Suspected Extremity Fractures.
    Reynolds SL; Bryant KK; Studnek JR; Hogg M; Dunn C; Templin MA; Moore CG; Young JR; Walker KR; Runyon MS
    Acad Emerg Med; 2017 Dec; 24(12):1430-1440. PubMed ID: 28926159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal fentanyl versus intravenous morphine in the emergency department treatment of severe painful sickle cell crises in children: study protocol for a randomised controlled trial.
    Barrett MJ; Cronin J; Murphy A; McCoy S; Hayden J; an Fhailí S; Grant T; Wakai A; McMahon C; Walsh S; O'Sullivan R
    Trials; 2012 May; 13():74. PubMed ID: 22647439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IF IM in a crisis: Intranasal fentanyl versus intravenous morphine in adult vaso-occlusive crisis.
    Assad O; Zamora R; Brown K; Melnitsky L; Moses J; Sherman V
    Am J Emerg Med; 2023 Feb; 64():86-89. PubMed ID: 36481614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analgesia for Children in Acute Pain in the Post-codeine Era.
    Poonai N; Zhu R
    Curr Pediatr Rev; 2018; 14(1):34-40. PubMed ID: 28847287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fentanyl Buccal Tablet: A New Breakthrough Pain Medication in Early Management of Severe Vaso-Occlusive Crisis in Sickle Cell Disease.
    De Franceschi L; Mura P; Schweiger V; Vencato E; Quaglia FM; Delmonte L; Evangelista M; Polati E; Olivieri O; Finco G
    Pain Pract; 2016 Jul; 16(6):680-7. PubMed ID: 26009799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variations in pediatric emergency medicine physician practices for intravenous fluid management in children with sickle cell disease and vaso-occlusive pain: A single institution experience.
    Carden MA; Patil P; Ahmad ME; Lam WA; Joiner CH; Morris CR
    Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28766843
    [No Abstract]   [Full Text] [Related]  

  • 17. Integrating palliative care and emergency medicine for optimal management of sickle cell pain in the wake of the United States opioid epidemic.
    Effiong A; Kumari P
    Ann Palliat Med; 2018 Apr; 7(2):274-276. PubMed ID: 29307211
    [No Abstract]   [Full Text] [Related]  

  • 18. Summary for Patients: Treating Pain in Adults With Sickle Cell Disease in an Infusion Center Versus the Emergency Department.
    Ann Intern Med; 2021 Sep; 174(9):I14. PubMed ID: 34224269
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of sex disparities in opioid use among ED patients with sickle cell disease, 2006-2015.
    Wilson TT; Chou SC; Becker S; Schuur JD; Beaudoin F
    Am J Emerg Med; 2021 Dec; 50():597-601. PubMed ID: 34592567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subanesthetic ketamine: the way forward for pain management in sickle cell disease patients?
    Nobrega R; Carullo V; Thein SL; Quezado ZMN
    Expert Rev Hematol; 2022 Oct; 15(10):887-891. PubMed ID: 36191299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.